http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632092-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-96 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-96 |
| filingDate | 2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106632092-B |
| titleOfInvention | A kind of 1,3- dimethyl -7- substituted quinazoline -2,4- cyclohexadione compounds and its synthetic method and application |
| abstract | The invention discloses one kind 1,3- dimethyl -7- substituted quinazoline -2,4- cyclohexadione compounds, the structural formula general formulas of the compound are as follows: Wherein R 1 For hydrogen or ethyl；R 2 For phenyl ring, phenyl ring derivative, heterocycle or aliphatic hydrocarbon.Part of compounds of the invention shows preferable inhibitory activity to Candida albicans, Aspergillus flavus, Cryptococcus neoformans and aspergillus fumigatus.And it is obvious to chitin synthesis enzyme inhibition activity, fungistatic effect is preferable, can be used for preparing the drug of resisting pathogenic microbes. |
| priorityDate | 2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.